These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 17845590

  • 1. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy.
    Price D, Wirén A, Kuna P.
    Allergy; 2007 Oct; 62(10):1189-98. PubMed ID: 17845590
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of budesonide/formoterol for maintenance and reliever asthma therapy in Denmark--cost-effectiveness analysis based on five randomised controlled trials.
    Wickstrøm J, Dam N, Malmberg I, Hansen BB, Lange P.
    Clin Respir J; 2009 Jul; 3(3):169-80. PubMed ID: 20298400
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*.
    Tamminen K, Laine J, Soini E, Martikainen J, Kankaanranta H.
    Curr Med Res Opin; 2008 Dec; 24(12):3453-61. PubMed ID: 19032127
    [Abstract] [Full Text] [Related]

  • 7. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R, Backer V, Kava TT, Omenaas ER, Sandström T, Jorup C, Welte T.
    Curr Med Res Opin; 2004 Dec; 20(2):225-40. PubMed ID: 15006018
    [Abstract] [Full Text] [Related]

  • 8. An economic evaluation of adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study.
    Price D, Haughney J, Lloyd A, Hutchinson J, Plumb J.
    Curr Med Res Opin; 2004 Oct; 20(10):1671-9. PubMed ID: 15462701
    [Abstract] [Full Text] [Related]

  • 9. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P.
    Clin Drug Investig; 2010 Oct; 30(9):565-79. PubMed ID: 20593912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
    Ställberg B, Ekström T, Neij F, Olsson P, Skoogh BE, Wennergren G, Löfdahl CG, SHARE trial group.
    Respir Med; 2008 Oct; 102(10):1360-70. PubMed ID: 18723335
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C, Naya I, Ekelund J.
    Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.